Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burnier

Showing results (31-40 of 284) with videos related to

Pageof 29
Sort By:
Idrugs : the Investigational Drugs Journal|August 17, 2005
Angiotensin II receptor antagonists: where do we stand?M Burnier, M Maillard
Revue Medicale Suisse|April 2, 2013
[Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease]O Phan, M Burnier
European Heart Journal|December 1, 1992
Neurohormonal consequences of diuretics in different cardiovascular syndromesM Burnier, H R Brunner
Kidney International. Supplement|December 5, 1998
Angiotensin II receptor antagonists in hypertensionM Burnier, H R Brunner
Current Opinion in Nephrology and Hypertension|September 1, 1994
Angiotensin II receptor antagonists and the kidneyM Burnier, H R Brunner
Revue Medicale Suisse|March 29, 2012
[Renin angiotensin system inhibitors: too much of a good thing can be dangerous]M Burnier, P-Y Martin
Journal of the American Society of Nephrology : JASN|April 14, 1999
Comparative antihypertensive effects of angiotensin II receptor antagonistsM Burnier, H R Brunner
Advances in Experimental Medicine and Biology|January 1, 1987
Protection from acute renal failureM Burnier, R W Schrier
The American Journal of Physiology|February 1, 1983
Pressor responses of rats to vasopressin: effect of sodium, angiotensin, and catecholaminesM Burnier, H R Brunner
Lancet (London, England)|March 4, 2000
Angiotensin II receptor antagonistsM Burnier, H R Brunner
Pageof 29

Showing results (31-40 of 284) with videos related to

Sort By:
Pageof 29
Idrugs : the Investigational Drugs Journal|August 17, 2005
Angiotensin II receptor antagonists: where do we stand?M Burnier, M Maillard
Revue Medicale Suisse|April 2, 2013
[Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease]O Phan, M Burnier
European Heart Journal|December 1, 1992
Neurohormonal consequences of diuretics in different cardiovascular syndromesM Burnier, H R Brunner
Kidney International. Supplement|December 5, 1998
Angiotensin II receptor antagonists in hypertensionM Burnier, H R Brunner
Current Opinion in Nephrology and Hypertension|September 1, 1994
Angiotensin II receptor antagonists and the kidneyM Burnier, H R Brunner
Revue Medicale Suisse|March 29, 2012
[Renin angiotensin system inhibitors: too much of a good thing can be dangerous]M Burnier, P-Y Martin
Journal of the American Society of Nephrology : JASN|April 14, 1999
Comparative antihypertensive effects of angiotensin II receptor antagonistsM Burnier, H R Brunner
Advances in Experimental Medicine and Biology|January 1, 1987
Protection from acute renal failureM Burnier, R W Schrier
The American Journal of Physiology|February 1, 1983
Pressor responses of rats to vasopressin: effect of sodium, angiotensin, and catecholaminesM Burnier, H R Brunner
Lancet (London, England)|March 4, 2000
Angiotensin II receptor antagonistsM Burnier, H R Brunner
Pageof 29